BRD4 and acute myeloid leukemia: To prove that dBET1-mediated degradation of the BRD family (i.e., BRD2, BRD3, and BRD4) has cytotoxic effects on AML cell lines, we determined the protein levels of the BRD family in four AML cell lines treated with increasing concentrations of dBET1.